- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
WHO expects to declare end to pandemic sometime in 2023 as virus becomes more like seasonal flu
March 17, 2023
From MarketWatch
7 Stocks Set to Soar When the Market Recovers
March 16, 2023
From InvestorPlace
From Benzinga
From MarketWatch
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
From Benzinga
From MarketWatch
From Motley Fool
How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising
March 03, 2023
From Benzinga
European Commission Keeps Mum On Talks Regarding Pfizer COVID-19 Vaccine Contract: Report
March 02, 2023
From Benzinga
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
February 24, 2023
From Benzinga
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
February 23, 2023
From Motley Fool
Overview Of Value Stocks In The Healthcare Sector
February 20, 2023
From Benzinga
Why Is Moderna (MRNA) Stock Down 5% Today?
February 17, 2023
From InvestorPlace
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
From Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
From Motley Fool
The 3 Most Undervalued Growth Stocks for Your February Buy List
February 06, 2023
From InvestorPlace
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
From Motley Fool
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
From MarketWatch
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
From Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
What investors need to know about Pfizer’s latest downgrade
January 26, 2023
From MarketWatch
Thursday Predictions: 3 Hot Stocks for Tomorrow
January 25, 2023
From InvestorPlace
From Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
January 20, 2023
From Benzinga
From Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
January 17, 2023
From InvestorPlace
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.